查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611805

磺胺類藥物市場：按形式、給藥途徑、分銷管道和應用分類 - 2025-2030 年全球預測

Sulphonamides Market by Form (Capsule, Liquid, Powder), Route of Administration (Oral, Topical), Distribution Channel, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年磺胺類藥物市值為1.0344億美元，預計到2024年將達到1.0852億美元，複合年成長率為5.79%，預計到2030年將達到1.5343億美元。

磺胺類藥物是一種合成抗菌劑，由於其廣泛的抗菌特性在製藥業中佔有重要地位。這種抗菌劑傳統上用於治療細菌感染疾病，其作用原理是抑制細菌中葉酸的合成，降低細菌的繁殖能力。全球細菌感染的持續威脅凸顯了對磺胺類藥物的需求，特別是在抗生素抗藥性高的地區。它的用途不僅限於人類醫學，甚至在獸醫學中也發揮著重要作用，並可作為化學合成的前體，進一步凸顯了其多功能性。最終用途多種多樣，包括製藥公司、獸醫醫院和專注於開發新抗菌策略的研究機構。

主要市場統計
基準年[2023] 1.0344億美元
預測年份 [2024] 10852萬美元
預測年份 [2030] 1.5343億美元
複合年成長率（%） 5.79%

磺胺類藥物市場的成長是由感染疾病發病率的增加以及抗菌素抗藥性上升對有效抗生素的迫切需求所推動的。由於醫療保健投資的增加和感染疾病的傳播，亞洲和非洲的新興市場尤其帶來了巨大的商機。然而，市場面臨挑戰，包括監管障礙和替代品的威脅，例如副作用較少的新型抗生素。此外，社會對磺胺類藥物對環境影響的擔憂限制了其廣泛使用，磺胺類藥物可以透過藥物廢棄物持續存在於生態系統中。

創新和研究至關重要，可能會在改良磺胺類藥物的開發中帶來突破，從而在保留療效的同時最大限度地減少抗藥性的產生。此外，標靶遞送系統的進步可能會提高治療指數。磺胺類藥物市場的競爭性和動態性以及對解決抗生素抗藥性的解決方案的持續需求正在推動對低抗藥性風險抗生素的研究投資。公司應重點關注與學術機構的策略合作夥伴關係以進行前沿研究，並與政府衛生機構合作以應對監管環境。最終，市場上的持續成功取決於創新與有效性、安全性和環境友善性的平衡。

市場動態：揭示快速發展的磺胺類藥物市場的關鍵市場洞察

供需的動態交互作用正在改變磺胺類藥物市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 世界各地慢性病的盛行率
    • 負擔得起的磺胺類藥物製劑的大量供應
    • 對磺胺製劑及其治療用途的認知
  • 市場限制因素
    • 磺胺類藥物藥物的副作用
  • 市場機會
    • 製藥公司加強研發力度
    • 醫療旅遊產業快速發展
  • 市場挑戰
    • 新興國家缺乏管理體制

波特的五力磺胺類藥物市場策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解磺胺類藥物市場的外部影響

外部宏觀環境因素在塑造磺胺類藥物市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解磺胺類藥物市場的競爭格局

對磺胺類藥物市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣磺胺類藥物市場供應商績效評估

FPNV定位矩陣是評估磺胺類藥物市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了磺胺類藥物市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對磺胺類藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的慢性病盛行率正在上升
      • 負擔得起的磺胺類藥物製劑的充足供應
      • 對磺胺類藥物及其治療用途的認知
    • 抑制因素
      • 磺胺類藥物藥物的副作用
    • 機會
      • 製藥公司加強研發力度
      • 醫療旅遊產業快速發展
    • 任務
      • 新興經濟體缺乏法律規範
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章磺胺類藥物市場：依形式

  • 膠囊
  • 液體
  • 粉末
  • 藥片

第7章磺胺類藥物市場：依給藥途徑分類

  • 口服
  • 話題

第8章磺胺類藥物市場：依分銷管道分類

  • 網路商店零售商
  • 商店型零售商

第9章磺胺類藥物市場：依應用分類

  • 胃腸道感染疾病
  • 呼吸道感染疾病
  • 皮膚感染疾病
  • 尿道感染

第10章 美洲磺胺類藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太磺胺類藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲磺胺類藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AA Pharma Inc.
  • Abbott Laboratories
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Cadila Pharmaceuticals Ltd.
  • Cipla Ltd.
  • F. Hoffmann La Roche Ltd.
  • Fera Science Limited
  • GlaxoSmithKline PLC
  • NorthStar Rx LLC
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
Product Code: MRR-62667ADF9D72

The Sulphonamides Market was valued at USD 103.44 million in 2023, expected to reach USD 108.52 million in 2024, and is projected to grow at a CAGR of 5.79%, to USD 153.43 million by 2030.

Sulphonamides, a class of synthetic antimicrobial agents, occupy a significant niche in the pharmaceutical industry due to their broad-spectrum antibacterial properties. Traditionally used to treat bacterial infections, they operate by inhibiting folic acid synthesis in bacteria, impairing their ability to multiply. The necessity of sulphonamides is underscored by the persistent threat of bacterial infections globally, particularly in regions with high antibiotic resistance. Their application extends beyond human medicine, finding roles in veterinary medicine and even as precursors in chemical synthesis-further underscoring their versatile nature. End-use scope is broad, covering pharmaceutical companies, veterinary clinics, and research institutions focused on developing new antibacterial strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 103.44 million
Estimated Year [2024] USD 108.52 million
Forecast Year [2030] USD 153.43 million
CAGR (%) 5.79%

Market growth for sulphonamides is driven by rising incidences of infectious diseases and the urgent need for effective antibiotics amid growing antimicrobial resistance. In particular, emerging markets in Asia and Africa present significant opportunities due to increasing healthcare investments and prevalence of infectious diseases. However, the market faces challenges such as regulatory hurdles and the threat of substitute drugs like newer antibiotic classes with fewer side effects. Additionally, public concern over the environmental impact of sulphonamides, which can persist in ecosystems through pharmaceutical waste, poses a constraint on their widespread use.

Innovation and research are pivotal, with potential breakthroughs in developing modified sulphonamides that retain efficacy while minimizing resistance development. Moreover, advances in targeted delivery systems could enhance their therapeutic index. The nature of the sulphonamide market is competitive yet dynamic, with ongoing need for solutions addressing antibiotic resistance-a call to action for investment in research toward low-resistance risk antibiotics. Companies should focus on strategic collaborations with academic institutions for cutting-edge research and partner with government health agencies to navigate regulatory landscapes. Ultimately, sustained market success hinges on balancing innovation with efficacy, safety, and environmental considerations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Sulphonamides Market

The Sulphonamides Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases worldwide
    • Substantial availability of affordable sulfonamide drug formulations
    • Awareness regarding sulpha drugs and its therapeutic uses
  • Market Restraints
    • Side effects of sulphonamides
  • Market Opportunities
    • Increasing research & development in pharmaceutical companies
    • Rapidly advancing medical tourism industry
  • Market Challenges
    • Lack of regulatory structure in emerging economies

Porter's Five Forces: A Strategic Tool for Navigating the Sulphonamides Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Sulphonamides Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Sulphonamides Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Sulphonamides Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Sulphonamides Market

A detailed market share analysis in the Sulphonamides Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Sulphonamides Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Sulphonamides Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Sulphonamides Market

A strategic analysis of the Sulphonamides Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sulphonamides Market, highlighting leading vendors and their innovative profiles. These include AA Pharma Inc., Abbott Laboratories, AbbVie Inc., Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Cipla Ltd., F. Hoffmann La Roche Ltd., Fera Science Limited, GlaxoSmithKline PLC, NorthStar Rx LLC, Novartis AG, Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Sulphonamides Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Form, market is studied across Capsule, Liquid, Powder, and Tablets.
  • Based on Route of Administration, market is studied across Oral and Topical.
  • Based on Distribution Channel, market is studied across Online-Store Retailers and Store-Based Retailers.
  • Based on Application, market is studied across Gastrointestinal Tract Infection, Respiratory Tract Infection, Skin Infections, and Urinary Tract Infection.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases worldwide
      • 5.1.1.2. Substantial availability of affordable sulfonamide drug formulations
      • 5.1.1.3. Awareness regarding sulpha drugs and its therapeutic uses
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of sulphonamides
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing research & development in pharmaceutical companies
      • 5.1.3.2. Rapidly advancing medical tourism industry
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of regulatory structure in emerging economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Sulphonamides Market, by Form

  • 6.1. Introduction
  • 6.2. Capsule
  • 6.3. Liquid
  • 6.4. Powder
  • 6.5. Tablets

7. Sulphonamides Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Oral
  • 7.3. Topical

8. Sulphonamides Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Online-Store Retailers
  • 8.3. Store-Based Retailers

9. Sulphonamides Market, by Application

  • 9.1. Introduction
  • 9.2. Gastrointestinal Tract Infection
  • 9.3. Respiratory Tract Infection
  • 9.4. Skin Infections
  • 9.5. Urinary Tract Infection

10. Americas Sulphonamides Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Sulphonamides Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Sulphonamides Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AA Pharma Inc.
  • 2. Abbott Laboratories
  • 3. AbbVie Inc.
  • 4. Bausch Health Companies Inc.
  • 5. Cadila Pharmaceuticals Ltd.
  • 6. Cipla Ltd.
  • 7. F. Hoffmann La Roche Ltd.
  • 8. Fera Science Limited
  • 9. GlaxoSmithKline PLC
  • 10. NorthStar Rx LLC
  • 11. Novartis AG
  • 12. Pfizer Inc.
  • 13. Sanofi S.A.
  • 14. Teva Pharmaceutical Industries Ltd.
  • 15. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. SULPHONAMIDES MARKET RESEARCH PROCESS
  • FIGURE 2. SULPHONAMIDES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SULPHONAMIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SULPHONAMIDES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SULPHONAMIDES MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SULPHONAMIDES MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES SULPHONAMIDES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES SULPHONAMIDES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. SULPHONAMIDES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. SULPHONAMIDES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SULPHONAMIDES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SULPHONAMIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SULPHONAMIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SULPHONAMIDES MARKET DYNAMICS
  • TABLE 7. GLOBAL SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SULPHONAMIDES MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SULPHONAMIDES MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SULPHONAMIDES MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SULPHONAMIDES MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SULPHONAMIDES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SULPHONAMIDES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SULPHONAMIDES MARKET SIZE, BY ONLINE-STORE RETAILERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SULPHONAMIDES MARKET SIZE, BY STORE-BASED RETAILERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SULPHONAMIDES MARKET SIZE, BY GASTROINTESTINAL TRACT INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SULPHONAMIDES MARKET SIZE, BY RESPIRATORY TRACT INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SULPHONAMIDES MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SULPHONAMIDES MARKET SIZE, BY URINARY TRACT INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES SULPHONAMIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. SULPHONAMIDES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. SULPHONAMIDES MARKET, FPNV POSITIONING MATRIX, 2023